sorafenib has been researched along with hydroxyl radical in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 10,147 | 26 | 3,657 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, Y; He, L; Liu, H; Liu, X; Ouyang, Y; Sun, Y; Tan, Y; Xu, T; Zhao, S | 1 |
1 other study(ies) available for sorafenib and hydroxyl radical
| Article | Year |
|---|---|
Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells.
Topics: Cell Line, Tumor; Copper; Glutathione; Humans; Hydrogen Peroxide; Hydroxyl Radical; Lipid Peroxides; Nanoparticles; Neoplasms; Oxidation-Reduction; Peroxides; Povidone; Sorafenib; Tumor Microenvironment | 2022 |